GLP-1 Weight Loss: What to Expect in the First 3 Months

Starting GLP-1 treatment raises a lot of questions. How quickly will it work? What will you feel? Is it working if the scale isn’t moving yet?

Here is a realistic, week-by-week picture of what most people experience in the first three months on semaglutide or tirzepatide.

Weeks 1–4: Starting low

Both semaglutide and tirzepatide begin at a low starting dose that is well below the therapeutic target. This is intentional — starting slow reduces side effects and lets your body adjust.

What you might notice:

• Mild nausea, especially after injections or large meals
• Slightly reduced appetite, even at low doses
• Little to no weight change yet — this is normal

The scale may not move much in the first month. That doesn’t mean the medication isn’t working. Your body is adjusting, and you’re not yet at a dose with full therapeutic effect.

Weeks 4–8: First dose increase

Around week 4, most providers increase the dose. This is typically when people start noticing more meaningful appetite suppression.

What you might notice:

• More significant reduction in hunger and food noise
• Feeling full faster and staying full longer
• Nausea may temporarily return after a dose increase, then settle
• Weight loss starting to become more consistent

This is the phase where most people start to feel the medication working in a tangible way. Portion sizes shrink naturally, and cravings become easier to manage.

Weeks 8–12: Building momentum

By weeks 8–12, most people have had at least one or two dose increases and are seeing more consistent results.

What you might notice:

• Steady weekly weight loss (typically 0.5–1.5 lbs per week on average, though it varies)
• Side effects largely settled for most people
• Improved relationship with hunger — not feeling controlled by it
• Non-scale changes: more energy, better sleep, clothes fitting differently

Clinical trials show that average weight loss at 12 weeks on semaglutide ranges from roughly 5–10% of starting body weight. Tirzepatide tends to produce slightly higher averages. But these are averages — individual response varies widely.

What affects your results

Several factors influence how quickly and how much weight you lose:

• Starting dose and titration schedule — higher doses generally produce more weight loss, but take time to reach safely
• Diet — the medication suppresses appetite but doesn’t replace intentional eating. Protein-focused nutrition supports better outcomes
• Activity — movement supports fat loss and muscle preservation
• Sleep and stress — both affect hunger hormones and water retention
• Individual biology — people simply respond differently

When to contact your provider

Reach out to your care team if you experience:

• Side effects that don’t improve after 2–3 weeks
• No appetite suppression at all after 4–6 weeks
• Questions about whether your dose should be adjusted

With Renlo, your semaglutide or tirzepatide treatment includes ongoing access to your care team throughout your journey — not just at the start.

---

This article is for general educational purposes only and is not medical advice. Individual results vary. Always work with a licensed provider to manage your treatment.